A carregar...
Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
Recently, a CTLA-4 antibody and BRAF inhibitors showed survival benefits in advance melanoma treatment. The documentation of immune infiltrates in melanomas early during BRAF inhibitor therapy provides a scientific rationale for combination therapy with both treatments with possible synergistic bene...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3489773/ https://ncbi.nlm.nih.gov/pubmed/23189245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19865 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|